Maybe; In the last several years large pharma companies have been developing biologics and have chosen to acquire smaller companies that have been developing small-molecule drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.